Navigation

TA196 Gastrointestinal stromal tumours - imatinib (adjuvant): audit support

Audit support is developed to support the implementation of NICE guidance. The aim is to assist organisations with the audit process, thereby helping to ensure that practice is in line with the NICE recommendations. It consists of audit criteria and data collection tool(s) and can be edited or adapted for local use.

Disclaimer

This resource is an implementation tool and should be used alongside the published guidance. The information does not supersede of replace the guidance itself.

This page was last updated: 05 January 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.